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Abstract Down syndrome (DS) is one of the most
common chromosomal abnormalities. Because of medical
advances and improvements in overall medical care, the
median survival of individuals with DS has increased
considerably. This longer life expectancy requires giving
the necessary care to the individual with DS over their total
longer lifespan. DS medical guidelines are designed for the
optimal care of the child in whom a diagnosis of DS has
been confirmed. We present an overview of the most
important issues related to children with DS based on the
most relevant literature currently available.
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Abbreviations
DS Down syndrome
OSAS Obstructive sleep apnea syndrome
AAI Atlanto-axial instability
RSV Respiratory syncytial virus
UTA Urinary tract anomalies
AD Atopic dermatitis
anti-tTG Anti-tissue transglutaminase antibodies
HLA Human leukocyte antibodies
Introduction
Down syndrome (DS) is the most common chromosomal
malformation in newborns. In Europe, DS accounts for 8%
of all registered cases of congenital anomalies. Throughout
the world, the overall prevalence of DS is 10 per 10,000
live births, although in recent years this figure has been
increasing. To a large extent, the prevalence of DS depends
on several socio-cultural variables. In countries where
abortion is illegal such as Ireland and the United Arab
Emirates, its prevalence is higher. Conversely, in France,
DS prevalence is low, and this is probably due to a high
percentage of DS pregnancy terminations [6, 21, 33]. In
The Netherlands, the most recent measure of DS prevalence
was 16 per 10,000 live births [33]. In the United Kingdom,
the prevalence of pregnancies affected by DS has increased
significantly, but there has been no overall change in the
live birth prevalence of DS. Increasing maternal age and
improved survival rates for infants with Down syndrome
have outweighed the effects of prenatal diagnosis followed
by the termination of pregnancy and a declining general
birth rate [6, 14, 24, 33, 36].
DS is characterized by several dysmorphic features and
delayed psychomotor development. Children with DS also
have an increased risk of concomitant congenital defects
and organic disorders such as congenital heart and
gastrointestinal defects, celiac disease and hypothyroidism
[21]. The median age at death of individuals with DS has
risen significantly in the US, from 25 years in 1983 to
49 years in 1997. Congenital heart defects (CHD) and
respiratory infections are the most frequently reported
medical disorders on death certificates for individuals with
DS [38]. Standardized mortality odds ratios (SMORs) in
DS were low for malignancies except for leukaemia and
testicular cancer, which were seen more often in individuals
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with DS [21, 39]. Recent decades have seen a substantial
increase in the life expectancy of children with DS. In The
Netherlands, the infant mortality rate in children with DS
dropped from 7.07% in 1992 to 4% in 2003 (this is in
contrast with the 0.48% infant mortality of the reference
population in The Netherlands in 2003) [33]. The fall in DS
mortality was mainly related to the successful early surgical
treatment of CHD and to the improved treatment of
congenital anomalies of the gastrointestinal tract [33]. The
life expectancy of children with DS is primarily dependent on
the risk of mortality in the first year of life. While modern
medical care has reduced the mortality rate to more acceptable
values, both morbidity and mortality could be further reduced.
In this respect, respiratory infections and neonatal problems
are the most important issues to be solved.
Since children with DS now have an improved life
expectancy, the total population of individuals with DS is
expected to grow substantially. Preventive health care pro-
grammes for these children will contribute to the improvement
of their overall outcome and quality of life; therefore, it is very
important to keep the medical guidelines updated [11, 21].
Newborn assessment
The characteristics of DS and specific clinical signs at birth
can guide the decision to perform karyotype testing for the
confirmation of a DS diagnosis (Table 1, Figs. 1, 2) [20,
30]. Hypotonia is the most striking characteristic, but others
include a “Simian fold”(Fig. 3), drinking problems, signs of
a CHD, a congenital defect of the gastrointestinal tract or
cataract. It will take several days before the first results of
the karyotyping can confirm a clinical suspicion of DS.
Initial postnatal support
The parents or caretakers of a child for whom a diagnosis of
DS is being considered or has been confirmed should be
informed in a supportive, positive, caring and honest
manner [26]. Because parents prefer to receive an accurate
and correct diagnosis, the information available to both the
paediatrician and the parents should be up-to-date. The
conversation must take place with both parents in a quiet
setting as soon as the diagnosis of DS is suspected, in the
presence of a paediatrician, an obstetrician and the child
with DS. The timing of the disclosure of specific DS-related
problems must be balanced with respect for the opportunity
for parents to welcome their child (Table 2) [19, 26].
Table 1 Characteristics of Down syndrome and specific clinical signs
at birth
Neonatal signs of Down syndrome [20, 30]
Most reliable
and discriminative signs
Small ears
Wide space in between the 1st
and 2nd toe (“Sandal gap”)
Small internipple distance
Brushfield spots
Nuchal skin fold
Reliable and discriminative signs Brachycephaly
Hypotonia
Flat face
Upward slant of the eye split
Transverse line in the palm
of the hand (“Simian fold”)
Age-dependent signs Epicanthic fold
Difficult to differentiate Low, flat nose bridge
Small mouth
Fig. 1 A 4-year-old boy with Down syndrome
Fig. 2 A 2-year-old girl with Down syndrome
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Cardiovascular disorders
The prevalence of CHD in neonates with DS is about 44–58%
worldwide. Atrioventricular septal defect and ventricular
septal defect are the most common forms of CHD, constitut-
ing up to 54% for ASD and to 33% for VSD, of all CHDs in
children with DS [31, 33]. A normal neonatal examination in
children with DS does not exclude a serious CHD. Because
of the high incidence of significant CHD in children with
Down syndrome, early recognition of CHD is necessary as it
can lead to the optimal management of the defect and can
sometimes prevent the development of pulmonary hyperten-
sion. The surgical correction of significant defects usually
takes place at the age of 2–4 months, though it is sometimes
performed earlier (e.g. in cases of Tetralogy of Fallot). An
elevated incidence (5.2–13.7%) of persistent pulmonary
hypertension of the neonate (PPHN) with DS has recently
been established, and there should be a specific focus on this
condition after birth [35]. Early assessment of the cardiac
condition of neonates with DS should always be performed
by echocardiography in the first month of life [8, 21, 35].
Vision disorders
Good vision is very important to the development of a
child, especially a child with developmental problems
such as those associated with DS. More than half of
children with DS have ocular abnormalities. In addition
to ocular features related to DS such as epicanthal folds,
narrowed or slanted palpebral fissures (the mongoloid
slant) and Brushfield spots (38–85%)(Fig. 4), these vision
disorders include strabismus (20–47%), nystagmus (11–
29%), congenital cataract (4–7%), acquired cataract (3–
15%), blepharitis (7–41%), refractive errors (43–70%) and
glaucoma (0.7%). Keratoconus is rare in childhood but
develops later in life in individuals with DS [27, 36].
Visual screening is essential for detecting defects that can
be treated. An early start is especially important in finding
congenital cataracts.
Ear, nose and throat disorders
Hearing impairment and otologic problems are prevalent in
children with DS, and these problems correlate substantially
with developmental problems. Midface hypoplasia is com-
mon in children with DS and consists of abnormalities of the
nasopharynx, abnormal Eustachian tube anatomy, abnormal
tooth development and agenesis of the teeth. These mid-face
problems, together with hypotonia and macroglossia (children
with DS have a relatively large tongue compared to the oral
cavity), are responsible for chronic middle ear disease and
chronic rhinorrhoea.
Allergy does not play an important role as a cause of
chronic rhinitis in children with DS [17]. On the other hand,
a variety of immune disorders makes them prone to upper
airway infections [4]. Even mild hearing loss can influence
educational, language and emotional developments, and as
a result, it can affect a child’s articulation skills. Regular
Fig. 3 Transverse line in the palm of the hand (“Simian fold”)
Table 2 Prevalence of medical problems in children with Down
syndrome
Prevalence
(%)
References
Congenital heart defects 44–58 [34]
Vision disorders 38–80 [21], [27]
Hearing disorders 38–78 [21]
Obstructive sleep apnoea syndrome 57 [25]
Wheezing airway disorders 30–36 [4]
Congenital defects of gastrointestinal
tract
4–10 [9]
Coeliac disease 5–7 [37]
Obesity 30–35 [30]
Transient myeloproliferative disorder 10 [39]
Thyroid disorders 28–40 [15], [28]
Atlanto-axial instability 10–30 [12]
Urinary tract anomalies 3.2 [16]
Skin problems 1.9–39.2 [18], [23]
Behaviour problems 18–38 [15], [21]
Fig. 4 Brushfield spots
Eur J Pediatr (2010) 169:1445–1452 1447
assessment of the hearing function is very important. An
active search for and treatment of chronic ear disease in
children with DS, started soon after birth, may improve
hearing [15]. Apart from hearing problems, children with DS
have delayed speech development [21]. Sleep-disordered
breathing in children with Down syndrome is seen in half of
the children with DS. The most common causes include
macroglossia, glossoptosis, recurrent enlargement of the
adenoid tonsils and enlarged lingual tonsils. There is a poor
correlation between parental impressions of sleep problems
and polysomnography results. Baseline polysomnography
must be considered in children with Down syndrome at 3 to
4 years of age [8, 25].
Respiratory disorders
Respiratory problems are responsible for the majority of the
morbidity and hospital admissions in children with DS.
Respiratory syncytial virus (RSV) is seen more frequently
and is associated with a greater risk for hospitalization in
children with DS. CHD does not influence the admission rate,
but children with CHD had longer lengths of hospital stay [4,
13]. Recurrent wheeze is very common among children with
DS (it is found in up to 36%) and is related to previous RSV
infection and to other factors such as tracheamalacia [3, 4].
The clinical picture may mimic asthma but is not equivalent
to asthma. These respiratory problems can in turn become
exacerbated because of the existence of CHD with haemo-
dynamic instability and as a result of hypotonia, both known
characteristics of DS. Other causal factors include airway
anomalies like tracheolaryngomalacia, pulmonary anatomical
changes like pulmonary hypoplasia, and subpleural cysts.
Subpleural cysts are common in individuals with DS (up to
36%) but are difficult to detect on plain chest films—CT
imaging is needed to detect them [2]. Furthermore, an
association with abnormal lung growth and lung hypoplasia
is found in children with DS [1]. RSV prophylaxis with
human monoclonal antibodies in children with DS with CHD
is common, but in a child without CHD, the prophylaxis has
to be considered because of their risk of the more frequent
and serious infections associated with RSV [3].
Gastrointestinal tract disorders
Congenital defects of the gastrointestinal tract are present in
4–10% of children with DS and play an important role in
morbidity during the first year of life. These defects include
oesophageal atresia/trachea-oesophageal fistula (0.3–0.8%),
pyloric stenosis (0.3%), duodenal stenosis/atresia (1–5%),
Hirschsprung disease (1–3%) and anal stenosis/atresia (<1–
4%).These defects are more frequent in the DS population,
as much as 25–30% of all cases of duodenal defects are in
children with DS [9]. Coeliac disease (CD) is another DS-
specific disorder and is seen in 5–7% of children with DS, a
rate that is ten times higher than in the normal population
[38]. Screening for early detection of CD in the DS
population, with the aim of starting treatment and prevent-
ing complications from untreated CD such as failure to
thrive, anaemia, osteoporosis and malignancy, seems to be
justified. For CD screening in children with DS, we
recommend human leukocyte antibodies (HLA)-DQ2 and
HLA-DQ8 typing in the first year of life with buccal swabs,
if available, which have the benefit of avoiding the
unpleasant collection of blood. Children who have negative
results for HLA-DQ2 or DQ8 (approximately 60%) can be
excluded from further screening, and parents can be
reassured that their child has no risk of CD. The remaining
children need to be monitored for CD by using IgA anti-
endomysium (EMA) and anti-tissue transglutaminase anti-
bodies (anti-tTGA) beginning at 3 years of age [15, 38].
The prenatal occurrence of an aberrant right subclavian
artery (ARSA, arteria lusoria) is substantially increased in
patients with DS where it is found in up to 19–36%. ARSA
may cause problems with the passage of solid food through
the oesophagus and dysphagia. Moreover, impaired oral
motor function, gastro-oesophageal reflux or congenital
disorders have to be considered as a cause in feeding
problems in children with DS [9, 22].
Constipation is a serious problem in children with DS
and is mainly a consequence of the hypotonia; however, in
serious cases, Hirschprung disease must be excluded [8].
Breastfeeding should be promoted not only because of
the psycho-emotional or immunity benefits but particularly
because breastfeeding has specific advantages for children
with DS in terms of stimulating the development of the oral
motor system [33]. However, because of their impaired oral
motor function, children with DS can have problems with
drinking, swallowing and chewing.
Overweight and overnutrition deserve serious attention
in children with DS [21].
Haemato-oncological and immunological disorders
Newborns with DS may have thrombocytopenia (up to
66%) and polycythaemia (up to 33%) [39]. The first must
be differentiated from pre-leukaemia while the latter may be
symptomatic and may cause hypoglycemia or respiratory
problems. Children with DS have an increased risk of
developing both acute myeloid as well as lymphoblastic
leukaemia. These leukaemias have specific presenting
characteristics and underlying biologies. Myeloid leukae-
mia in children with DS may be preceded by a preleukae-
mic clone (transient myeloproliferative disorder, TMD),
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which may disappear spontaneously but may need treat-
ment when symptoms are severe. TMD presents in 10% of
children with DS. Twenty percent of children with transient
leukaemia subsequently develop myeloid leukaemia, usu-
ally with an onset before the age of 5 [39]. Children with
DS have lowered T- and B-lymphocyte counts and
functions which may explain part of their susceptibility to
infections. On the other hand, there is a lower allergy risk in
children with DS [4, 17, 18, 23, 39]. There is no specific
clinical picture in relation to disturbances of the immune
system, which means that screening is not useful.
Endocrine disorders
In neonates with DS, the Gaussian distribution of thyroxin
and TSH values are shifted to the left, and there may be a
DS-specific thyroid dysregulation. Thyroxin has been given
to newborns during the first 24 months, and although short-
term follow-up showed some benefit to development and
growth, there is no data available on the long-term benefit
of treating these children with thyroxin [10, 28, 29].
Therefore, this treatment is not commonly used.
Thyroid disorders have been reported in up to 28–40% of
children with DS, and they increase in frequency, up to 54%,
as the children age [10, 15, 28]. Thyroid abnormalities in
children with DS range from congenital hypothyroidism
(1.8–3.6%) to primary hypothyroidism, autoimmune
(Hashimoto) thyreoiditis (0.3–1.4%) and compensated
hypothyroidism (25.3–32.9%). In addition, hyperthyroid-
ism (Graves’ disease) (0–2%) occurs in children with DS as
well. Compensated hypothyroidism or isolated raised
thyroid stimulating hormone (IR-TSH) is most frequently
present in children with DS and is characterized by mildly
elevated TSH with normal or low normal free T4; it often
has a self-limiting natural history [10]. These thyroid
antibodies are the second most frequently present, and
when present, they can cause manifest hypo-or hyperthy-
roidism within 2 years in almost 30%, but these antibodies
are as such not primary related to abnormal thyroid function
[10, 15, 28]. Most predictive of the development of
hypothyroidism is the presence of both elevated TSH and
antibodies, and those children should be tested more
frequently than other children with DS [9]. When both are
normal in the first decade of life, there is a low probability
of hypothyroidism in the second decade [10]. Interestingly,
diabetes mellitus develops more frequently (1%) in children
with Down syndrome [21, 30].
Children with DS have their own growth pattern and
DS-specific growth curves [7].The follow-up of length and
weight in children with DS should be part of the regular
medical screening and special attention for the weight is
warranted because children with DS are prone to over-
weight. Their lack of feeling of satisfaction and their
unlimited food intake, as well as their moderate exercise
pattern, need special attention [21].
Orthopaedic disorders
The motoric system of children with DS is characterized by
ligamentous laxity, joint hypermobility and hypotonia
presenting in a variety of ways [5, 15]. Craniocervical
instability has been reported in 8% to 63% of children with
DS; atlanto-axial instability (AAI) occurs in 10% to 30%.
The majority of cases are asymptomatic with symptomatic
disease occurring in 1% to 2%, particularly as the result of
an accident [12]. There are limitations regarding both
obtaining and interpreting and screening X-rays for AAI,
and these are not predictive for injury. The performance of
yearly neurologic screening is advisable, as is taking extra
care when intubation is necessary. Sport activities, includ-
ing somersaults, can be part of these patients’ activities as
long as there is a good support [5, 12, 21]. Individuals with
DS have been described as having a specific gait, with
external rotation of the hips, knees in flexion and valgus,
and externally rotated tibias. In childhood, pes planovalgus
is often seen, and in cases where marked pronation of the
foot creates problems with stable ambulation, active
support is warranted [21] (Fig. 5).
Acquired hip dislocation occurs in up to 30% of children
with DS and needs special attention. Patellofemoral
instability is estimated to occur in 10–20% of children
with DS; slipped capital femoral epiphysis is seen more
often in children with DS and has a poor prognosis [5].
Most of these disorders manifest themselves once children
with DS start walking, around 2–3 years of age [5]. An
arthropathy similar to juvenile rheumatoid arthritis can
Fig. 5 Valgus posture of the ankle and pes planus, a typical example
of joint laxity
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develop in children with DS but is rare [5]. The delay in
motor development in children with DS is more pro-
nounced than the delay in mental development. Delays in
motor development appear to be particularly related to the
degree of hypotonia, which negatively influences develop-
ment and leads to problems in postural control and to
typically static and symmetrical movement patterns, com-
pensatory movement strategies, and lack of movement
variability. Limitations in the functional activities of 5 to 7-
year-old children with Down syndrome seem to be more
related to the level of motor ability than to the level of
performance of mental ability [32]. Special attention to
motor development and counselling by a physiotherapist is
advised.
DS directed physiotherapy supports the development of
the basic gross motor skills properly by challenging the
children with DS and giving them confidence in their own
physical abilities by making use of the knowledge of the
typically movement patterns of DS, furthermore to support
parents to start active play and sports.
Urinary tract disorders
Children with DS have significantly more risk of urinary
tract anomalies (UTAs) (3.2%). Symptoms may be masked
because voiding disturbances and delayed toilet training are
usually interpreted as a consequence of delayed psychomotor
development. UTAs such as hydronephrosis, hydroureter, renal
agenesis and hypospadias must be considered in children with
DS. Routine screening by ultrasound is not yet standard, but
paediatricians should not overlook this problem [16].
There are no specific guidelines towards the attitude in
delay in daytime and nighttime continence in children with
DS; besides the standard treatment, visual instruction is
helpful as well as showing them how to do. The advice is to
start training at the moment the child can sit properly and
understand the items stool, urine and toilet.
Sexual development
In adolescent girls with DS, the onset of puberty is similar
to that of other adolescents. In boys with DS, the primary
and secondary sexual characteristics and pituitary and
testicular hormone concentrations are similar to those in
typical adolescents [21]. Females with DS are able to have
children, but males with DS have a diminished capacity to
reproduce [21]. Education to prevent pregnancies is
warranted, specific in children with DS who discuss
sexuality open-hearted. In girls, contraception can only be
discussed when their mental development enables them to
understand the subject.
Furthermore, contraception can be given to prevent
pregnancy or when there are problems with the menstrual
cycle, for fear of blood or problems with the hygiene.
Unfortunately one must be cautious for sexual abuse in
girls with DS.
Timeline for medical assessment of children with Down syndrome
0–3 months 4–12 months Every year Note
Genetic counselling + Once, after birth
Cardiac Ultrasound + + Follow-up depends on the heart defect
Visiona + + Every 3 years
Hearing + + +
OSAS + Polysomnography at 3–4 years
Periodontal + Dental agenesis
Constipation + + +
Coeliac disease + Every 3years TGA,
once HLA-DQ2 and 8b
Growth/Overweight + Specific Downcurves- length/weight
Haematology + + TMD at first, leukaemia
mainly first 5 years
Thyroid function + +
Hips/Patellae + + +
AAI + neurologic screening, care during
intubation
Physiotherapy + + + Most impact in first 4 years
Skin +
(Pre)Logopaedic + + + Until speech is well established
Table 3 Screening schedule for
children with Down syndrome
0–18 years
OSAS Obstructive sleep apnoea
syndrome
a Initial check for congenital cata-
ract and later for visual assessment
b HLA-DQ 2and 8 when negative,
stop when one or both is positive,
anti-tissue transglutaminase anti-
bodies (anti-tTGA) every 3 years
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Dermatologic problems
Dermatologic diseases are often present and are especially
troublesome in adolescents [21]. Alopecia areata (2.9–
20%), vitiligo (1.9%), seborrhoeic eczema (8–36%), follic-
ulitis (10.3–26%) and syringoma (12.3–39.2%) are more
frequently seen in children with DS. Rare but DS-specific
problems are elastosis perforans serpiginosa and milia-like
idiopathic calcinosis cutis [18, 23]. A previously reported
high prevalence of atopic dermatitis (AD) in up to 56.5% of
children with DS is probably an overestimation, as more
recent studies suggest a lower prevalence of 1.4–3%. This
could be the result of new and different diagnostic criteria
for AD. This observation also notes a lower allergy risk in
children with DS, which is in concordance with the studies
on allergic rhinitis [17, 18, 23].
Neuro-behavioural disorders
Most children with DS function in the low range of typical
development, and their intelligence quotient decreases in
the first decade of life. In adolescence, cognitive function
may reach a plateau that persists in adulthood. Mental
development shows a deceleration between the ages of
6 months and 2 years [32]. IQ values vary, usually ranging
from 35 to 70, indicating mild to moderate mental
impairment; severe mental impairment is only occasionally
seen in children with DS [8]. Counterproductive behaviour
and avoidance tactics can impede learning, and language
production is often substantially impaired. Delayed verbal
short-term memory and expressive language indicate the
need for a special approach to teaching these children to
speak (for example, learning to speak by first learning to
read) [15, 21]. Furthermore, impaired oral motor function
can influence articulation.
Children with DS have more pronounced neuro-
behavioural and psychiatric problems, found in 18% to
38%. The most frequent problems are disruptive behaviour
disorders, such as attention deficit hyperactivity disorder
(6.1%), conduct/oppositional disorder (5.4%) or aggressive
behaviour (6.5%), and obsessive–compulsive disorders.
More than 25% of adults with DS have a psychiatric
disorder, most frequently a major depressive disorder
(6.1%) or aggressive behaviour (6.1%) [15, 21]. A diagnosis
of autism or autism spectrum disorders in children with DS
is found in 7%. This diagnosis is not easily made in
children with DS mainly because of the resemblance and
overlap of DS-specific behaviours and autism.
Epilepsy is seen in 8% of children with DS, with 40%
occurring in infancy and often presenting as infantile
spasms. Alzheimer’s disease which is associated with DS
appears later in life, not in childhood [21].
Education and school
Early intervention education systems are programmes that
can be used from the first months of life and provide tools
to stimulate the development of children with DS, espe-
cially in the preschool period. Children with DS often begin
primary school with extra support; successful outcomes are
mainly in the area of social skills as a result of the ability to
copy and mirror behaviour. The outcome for adult social
independence depends largely on the development of
abilities to complete tasks without assistance, the willing-
ness to separate emotionally from parents and access to
personal recreational activities [21].
Conclusion and recommendations
Children with DS have several DS-specific morbidities
and screening programmes are available to support and
educate patients and their families. Although the most
frequently occurring morbidities are emphasized, a poten-
tial drawback is that a child with DS might have rare DS-
specific problems, but children with DS can also have the
same problems as their healthy peers. Today children with
DS have a better life expectancy, which means that the
total population of individuals with DS is expected to
grow substantially. There should be a focus on probable
changes in long-term DS morbidity. Furthermore, we need
to address the quality of this longer life span. Our
recommendations for regular screening are shown in
Table 3.
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